These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 12028455)

  • 21. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria.
    Ardiles LG; Loyola F; Ehrenfeld P; Burgos ME; Flores CA; Valderrama G; Caorsi I; Egido J; Mezzano SA; Figueroa CD
    Kidney Int; 2006 Jan; 69(1):53-9. PubMed ID: 16374423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure.
    MacLaughlin M; Monserrat AJ; Muller A; Matoso M; Amorena C
    Kidney Blood Press Res; 1998; 21(5):329-34. PubMed ID: 9851320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: involvement of B1 and B2 receptors.
    Gouin L; Cardinal R; Adam A; Drapeau G; Nadeau R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):337-43. PubMed ID: 8856493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unilateral renal denervation and the renal kallikrein-bradykinin system in the rat].
    Bohlender J; Nussberger J; Amstutz C; Birkhäuser F; Thalmann GN; Imboden H
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):144-8. PubMed ID: 23746686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
    Bao G; Gohlke P; Unger T
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria.
    Ardiles L; Cardenas A; Burgos ME; Droguett A; Ehrenfeld P; Carpio D; Mezzano S; Figueroa CD
    Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1399-410. PubMed ID: 23552867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
    Sakamoto T; Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.
    Buléon M; Allard J; Jaafar A; Praddaude F; Dickson Z; Ranera MT; Pecher C; Girolami JP; Tack I
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1249-56. PubMed ID: 18367657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does insulin release kinins in rats?
    Damas J; Garbacki N; Lefèbvre PJ
    Eur J Pharmacol; 2005 Nov; 525(1-3):154-60. PubMed ID: 16297383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
    Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
    Campbell DJ; Kladis A; Briscoe TA; Zhuo J
    Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
    Yosipiv IV; el-Dahr SS
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.